Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic LeukemiaMarco L. Davila, Renier J. Brentjens, Himaly Shinglot et al.|Science Translational Medicine|2014Cited by 2.5k
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escapeMohamad Hamieh, Michel Sadelain, Anton Dobrin et al.|Nature|2019Cited by 659
GPRC5D-Targeted CAR T Cells for MyelomaSham Mailankody, Eric L. Smith, Sean M. Devlin et al.|New England Journal of Medicine|2022Cited by 383
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapyMelody Smith, Marco Ruella, Anqi Dai et al.|Nature Medicine|2022Cited by 308
HLA-independent T cell receptors for targeting tumors with low antigen densityJorge Mansilla‐Soto, Michel Sadelain, Justin Eyquem et al.|Nature Medicine|2022Cited by 184